All Articles

Browse all articles — filter by topic, how strong the science is, or date.

Showing 2929–2952 of 3,522

Apr 2, 2026globenewswire.com

Revolution Medicines Begins Treating Patients in Phase 3 RASolute 303 Trial Evaluating Daraxonrasib as First Line Treatment for Patients with Metastatic Pancreatic Cancer

generalTreatments & Drugs

Apr 2, 2026globenewswire.com

MiNK Therapeutics to Present New Data at ASGCT 2026 Highlighting Context-Dependent Activity of iNKT Cell Therapy

generalIndustry & Access

Apr 2, 2026globenewswire.com

Plus Therapeutics Secures Highmark Coverage for CNSide® CSF Assay, Expanding Reimbursement to ~75 Million Covered Lives

generalIndustry & Access

Apr 2, 2026longevity.technology

The ‘rising tide’ of mitochondrial therapies in longevity

significantIndustry & Access

Apr 2, 2026sciencedaily.com

This simple Japanese eating habit could help you live longer without dieting

generalFood & Lifestyle

Apr 2, 2026globenewswire.com

Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte’s TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC)

general

Apr 2, 2026globenewswire.com

Neutrolis Announces Positive First-in-Human Phase 1a Results from LIBERATE-I Trial of NTR-1011, a First-in-Class DNASE1L3 Fusion Protein

general

Apr 2, 2026globenewswire.com

Skye Bioscience Treats First Patient in Nimacimab Higher-Dose Expansion Study Evaluating Exposure-Response to Inform Phase 2b Dose Selection for GLP-1 Combination Development

generalTreatments & Drugs

Apr 2, 2026longevity.technology

SpectraCell packages longevity, early disease detection in one kit

generalIndustry & Access

Apr 2, 2026longevity.technology

Rhythm posts first FDA approval for acquired hypothalamic obesity

landmarkIndustry & Access

Apr 2, 2026fightaging.org

NR0B2 is Protective of Cartilage, But Expression Decreases as Osteoarthritis Progresses

significantScience & Tech

Apr 2, 2026fightaging.org

Severe Infection Correlates with Greater Risk of Later Dementia

generalMeasuring Aging

Apr 2, 2026globenewswire.com

Immunovant Announces Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)

generalTreatments & Drugs

Apr 2, 2026globenewswire.com

Roivant Announces Expansion of Brepocitinib Development Program with New Phase 2b/3 Trial in Lichen Planopilaris (LPP) and Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)

generalTreatments & Drugs

Apr 2, 2026sciencedaily.com

Scientists create “smart” DNA drug that targets cancer cells with extreme precision

general

Apr 2, 2026longevity.technology

Annovis publishes historical review of Buntanetap

landmarkIndustry & Access

Apr 2, 2026longevity.technology

Humanaut to open Dallas clinic, launches founding membership presale

generalMeasuring Aging

Apr 2, 2026longevity.technology

Agentis, Ultrahuman tie wearables to Longevity Quotient

significantMeasuring Aging

Apr 2, 2026longevity.technology

I-Lumen receives FDA IDE to start U.S. i-SIGHT2 enrollment

significantIndustry & Access

Apr 2, 2026sciencedaily.com

Scientists discover “molecular shredder” that helps deadly parasite evade the immune system

generalScience & Tech

Apr 2, 2026sciencedaily.com

What’s hiding inside colon cancer could change treatment

significantScience & Tech

Apr 2, 2026globenewswire.com

Good oral health isn't complicated — Alberta's dentists want you to know what works

generalFood & Lifestyle

Apr 1, 2026globenewswire.com

Beam Therapeutics Announces Publication of BEACON Phase 1/2 Data for risto-cel in Patients with Sickle Cell Disease (SCD) in The New England Journal of Medicine

generalScience & Tech

Apr 1, 2026globenewswire.com

Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies

generalIndustry & Access